158 related articles for article (PubMed ID: 38195816)
1. Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Zheng J; Liu F; Tuo J; Chen S; Su J; Ou X; Ding M; Chen H; Shi B; Li Y; Chen X; Wang C; Su C
Mol Biotechnol; 2024 May; 66(5):1132-1143. PubMed ID: 38195816
[TBL] [Abstract][Full Text] [Related]
2. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
3. Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Stein J; Klümper N; Zöhrer P; Büttner T; Krausewitz P; Ritter M; Kristiansen G; Toma M; Ellinger J; Cox A
Cureus; 2024 Jan; 16(1):e53038. PubMed ID: 38410284
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumour. Optimal treatment strategies.
Suryanarayan K; Marina N
Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
6. Relationship of tumour-associated macrophages with poor prognosis in Wilms' tumour.
Tian K; Wang X; Wu Y; Wu X; Du G; Liu W; Wu R
J Pediatr Urol; 2020 Jun; 16(3):376.e1-376.e8. PubMed ID: 32299765
[TBL] [Abstract][Full Text] [Related]
7. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
9. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.
Vujanić GM; Parsons LN; D'Hooghe E; Treece AL; Collini P; Perlman EJ
Histopathology; 2022 Jun; 80(7):1026-1037. PubMed ID: 35275409
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
12. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
13. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
Ora I; van Tinteren H; Bergeron C; de Kraker J;
Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
[TBL] [Abstract][Full Text] [Related]
14. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
15. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor: single centre retrospective study from South India.
Guruprasad B; Rohan B; Kavitha S; Madhumathi DS; Lokanath D; Appaji L
Indian J Surg Oncol; 2013 Sep; 4(3):301-4. PubMed ID: 24426744
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
[TBL] [Abstract][Full Text] [Related]
18. Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group.
Vujanić GM; D'Hooghe E; Vokuhl C; Collini P
Histopathology; 2021 Nov; 79(5):678-686. PubMed ID: 33942359
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and glutathione-associated enzymes in Wilms' tumour after chemotherapy.
Gajewska J; Szczypka M; Izbicki T; Klepacka T; Laskowska-Klita T
J Cancer Res Clin Oncol; 1996; 122(8):483-8. PubMed ID: 8698748
[TBL] [Abstract][Full Text] [Related]
20. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.
Gururangan S; Dorman A; Ball R; Curran B; Leader M; Breatnach F; O'Meara A
J Clin Pathol; 1992 Jun; 45(6):498-501. PubMed ID: 1320635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
